• Home
  • Business News
  • Weekly Reviews
  • Market Reports
Monday, June 9, 2025
  • Login
  • Home
  • Business News
  • Weekly Reviews
  • Market Reports
  • Global Markets
  • Commodities
  • Corporate News
No Result
View All Result
The Trading Room
  • Home
  • Business News
  • Weekly Reviews
  • Market Reports
  • Global Markets
  • Commodities
  • Corporate News
No Result
View All Result
The Trading Room
No Result
View All Result
Home Global Markets

U.S Markets Rise as Gilead Data Offsets Virus Fears

Trading Room Reporter by Trading Room Reporter
in Global Markets
Reading Time: 2 mins read
A A
0
Nasdaq Wall Street

NASDAQ

Share on FacebookShare on Twitter

US stocks rose on Friday as a positive analysis on Gilead Sciences Inc’s antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States, and as financial shares surged.

RELATED POSTS

US Stock Market Sinks as Tariff Tensions Overshadow Economic Data

Asian Markets Gain as Yuan Falls to Lowest in 17 Years

US Stock Markets Soar Amid Trump’s Tariff Pause Announcement

The Nasdaq posted its sixth record closing high in seven days, but the index underperformed both the Dow and S&P 500, in a reversal of the recent trend.

The S&P 500 financials index rose 3.5%, leading sector gains and giving the S&P 500 its biggest boost. Bank of America Corp (BAC.N) shares increased 5.5%, Citigroup Inc (C.N) jumped 6.5% and JPMorgan Chase & Co (JPM.N) climbed 5.5% ahead of their financial results next week, which will mark the onset of the second-quarter earnings season.

Rob Haworth, senior investment strategist at U.S. Bank Wealth Management in Seattle, said there was a rotation “from winners into laggards” in Friday’s trading, with the earnings period around the corner.

The United States registered the largest single-day increase in new COVID-19 infections globally for the second day in a row on Thursday, forcing Americans to take new precautions. Several states have already backpedaled on reopening plans.

Gilead’s (GILD.O) remdesivir significantly improved clinical recovery and reduced the risk of death in COVID-19 patients, additional data from a late-stage study showed. The drugmaker’s shares climbed 2.2% as it said the finding required confirmation in clinical trials.

“That kind of dampened some of the concern that’s been building over the past few days around the increased virus cases in the southern states,” said Charlie Ripley, senior investment strategist for Allianz Investment Management in Minneapolis.

Buy JNews
ADVERTISEMENT

The Dow Jones Industrial Average rose 369.21 points, or 1.44%, to 26,075.3, the S&P 500 gained 32.99 points, or 1.05%, to 3,185.04 and the Nasdaq Composite added 69.69 points, or 0.66%, to 10,617.44.

For the week, the Dow rose 1%, the S&P 500 gained 1.8% and the Nasdaq jumped 4%. The Cboe Volatility index ended down on the day and fell 0.39 points for the week.

Overall profits for S&P 500 companies are expected to have fallen more than 40% in the second quarter, which would be the biggest quarterly profit decline since the financial crisis, according to IBES data from Refinitiv.

The first coronavirus cases in the United States were identified in January and within weeks much of the economy was shut down to slow the spread, throwing millions of Americans into unemployment. Companies across a range of industries have been dealing with the aftermath ever since.

The S&P 500 is up more than 40% from its March 23 bottom, thanks in part to economic data that has pointed to a revival in business activity in June.

Carnival Corp (CCL.N) jumped 10.8% after the cruise line operator said it was planning to resume operations in a phased manner and would operate with a smaller fleet on its return.

Netflix Inc (NFLX.O) rose 8.1% after Goldman Sachs hiked its price target on the video streaming service’s shares.

Advancing issues outnumbered declining ones on the NYSE by a 2.87-to-1 ratio; on Nasdaq, a 1.62-to-1 ratio favored advancers.

The S&P 500 posted 19 new 52-week highs and no new lows; the Nasdaq Composite recorded 85 new highs and 17 new lows.

Volume on U.S. exchanges was 9.57 billion shares, compared with the 11.93 billion average for the full session over the last 20 trading days.

Post Views: 970
Tags: Corona Virus PandemicDow Jones Industrial AverageNASDAQNew York Stock ExchangeS&P 500 IndexWall Street
Previous Post

Market Report: 10 July, 2020

Next Post

The Trading Room: Weekly Market Review – Week 28, 2020

Trading Room Reporter

Trading Room Reporter

Related Posts

US Stocks market Wallstreet data
Global Markets

US Stock Market Sinks as Tariff Tensions Overshadow Economic Data

by Felix Ochieng
Global Markets Asian markets
Asian Stock Markets

Asian Markets Gain as Yuan Falls to Lowest in 17 Years

by Githere Eddie
Donald Trump US Stock Markets Tarrifs
Global Markets

US Stock Markets Soar Amid Trump’s Tariff Pause Announcement

by Trading Room Reporter
US Stock Markets
Global Markets

US Stock Markets Tumble as Tariff Deadline Looms

by Rennie Odek
Next Post
The Trading Room: Weekly Market Review – Week 28, 2020

The Trading Room: Weekly Market Review – Week 28, 2020

Asian Markets Jump on Monday as Investors Shrug off Rising COVID-19 Cases

Standard Investment Bank Ranked top Hedge Fund Manager in Kenya

Mansa-X Annualized Return at 20.3% for 1H2020 Despite COVID-19.

Advertisement Banner Advertisement Banner Advertisement Banner
ADVERTISEMENT

Most Viewed Posts

  • Tea Farmers Set to Receive Kes 28 Billion as Final Bonus Payment (4,121)
  • 4 Things You Can Do With the Cashlet App to Achieve Your Financial Goals (2,212)
  • Hilda Njeru Takes over at CDSC (2,083)
  • Safaricom Finally Launches eSIM: Here’s What You Need to Know (1,937)
  • KenGen Gets Nod to Sell 4 Million Tonnes of Carbon Credits (1,818)

Follow Twitter

About Us

Follow Us

Popular Tag

Africa Asian - Pacific Stocks Asian Stock Markets Australian Stocks Bitcoin Bonds Kenya Bonds Trading in Kenya Brent Brent Crude Capital Markets Authority Central Bank of Kenya Corona Virus Pandemic Crude Oil Cryptocurrencies Derivatives NSE Derivatives Trading in Kenya Dow Jones Industrial Average Ethereum European Stock Markets Global Economy Global Markets Hang Seng Index Investing in Kenya Investor Briefing Jakarta Stock Exchange Kenya Economy Kospi index MSCI Index Nairobi Securities Exchange NASDAQ New York Stock Exchange Nikkei N225 NSE Oil Futures S&P 500 Index Safaricom Plc Shanghai Composite Shenzhen component spotlight Stock Market Report Stock Market Review U.S. Stock markets US oil Wall Street WTI Oil Index

Recent News

Part of the delegates who participated in the 2025 Tanzania – Uganda Trade and Investment roadshow, during a site visit to GALCO LIMITED, a member of GSM Group Of Companies, in Dar es Salaam.

Equity Group Leads Trade and Investment Mission to Uganda and Tanzania

HF Group Plc CEO Robert Kibaara

Opinion: HF Group Delivering Transformation and Strategic Growth

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 The Trading Room Limited.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
TSLA 
$295.14  3.67%  
GME 
$29.58  0.44%  
MSFT 
$470.38  0.58%  
AAPL 
$203.92  1.64%  
AMC 
$3.40  0.00%  
ABNB 
$140.64  2.44%  
GOOGL 
$173.68  3.25%  
AMZN 
$213.57  2.72%  
No Result
View All Result
  • Home
  • Business News
  • Weekly Reviews
  • Market Reports

© 2025 The Trading Room Limited.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?